A smartphone that moves, tracks and responds in real time—but is it real utility or just a marketing gimmick?
Updated
April 15, 2026 6:00 PM

HONOR Robot Phone, with its camera arm extended. PHOTO: HONOR
Smartphones today feel more familiar than new. Each year brings better performance and better cameras, but fewer real surprises. So when a company unveils something called a “Robot Phone”, it’s bound to get attention.
HONOR did exactly that at the Mobile World Congress (MWC) in Barcelona this year. While most smartphone brands are focused on software upgrades, HONOR is trying something different with hardware. Its Robot Phone is built to move and adjust on its own. The camera sits on a motorized system that can tilt, track motion and shift angles automatically. It almost looks like a small robotic head, following whatever is happening in front of it. It can pick up sound, recognize motion and stay visually aware of its surroundings. This result feels less like using a regular phone and more like interacting with something responsive.
So what makes HONOR’s Robot Phone different from the smartphones we already use? Here’s a closer look at its camera system, AI features and design, and whether it is truly something new or simply smart marketing.
At its core, the Robot Phone still works like a regular smartphone. What makes it different is the camera system. It has a 200MP camera that sits on a motorized arm with a three-axis gimbal, which extends when in use and folds back into the phone when not needed. The compact motor gives the camera physical movement, while motion control allows it to sense, track and follow a person or object in real time. That means it can keep a subject in frame without constant manual adjustment.
The camera also adds a more playful side to the experience. It can respond with simple gestures, such as nodding or shaking its head, and it can even move in sync with music.
This setup could be particularly useful for content creators. As CNET tech journalist and YouTuber Andrew Lanxon pointed out, it removes the need to carry a separate gimbal. Since the robotic camera module can easily fold into the body of the phone, it is easier to carry around and more convenient for filming or taking photos on the go.
The Robot Phone also has the practical advantage of a smartphone display. It gives users a bigger screen than a standalone camera for framing, monitoring and reviewing footage. Since it runs on Android, the process of recording, editing and sharing content is also more direct.
The most impressive part of the HONOR Robot Phone design is how it fits a moving camera system into the body of a smartphone without needing external attachments.
To make this possible, HONOR uses a custom micro motor that is 70% smaller than mainstream competitors. The company also says it is the industry’s smallest four-degrees-of-freedom (4DoF) gimbal system. To support the stable movement of the camera module, the internal structure uses high-strength materials such as steel and titanium alloy. These materials help the mechanism stay durable as it shifts and repositions over time.
Battery life is another obvious question. HONOR has not revealed the battery capacity of the Robot Phone itself, but it did showcase its Silicon-Carbon Blade Battery technology at MWC 2026. The company says this battery is designed to increase energy density while keeping devices slim, and that it could support capacities of 7,000 mAh and beyond in future foldable devices.
That is not specific to the Robot Phone, but it does hint at the kind of battery improvements that may be needed for smartphones with moving parts and more advanced camera systems.
The AI features in Honor’s Robot Phone are focused on how the device sees and responds to its surroundings in real time. At the most basic level, the phone can track what is happening in a scene and adjust itself without constant user input.
On the functional side, the system keeps subjects framed and in focus automatically. Its AI Object Tracking ensures subjects stay centred, while AI SpinShot enables controlled 90° and 180° rotations for smoother transitions, even when the phone is used one-handed. It can also detect motion and recognize sound, which lets it respond to activity as it happens instead of reacting frame by frame.
The AI becomes more noticeable in the way the device behaves. When activated, the camera module unfolds and the screen displays a pair of animated eyes that track the user’s face and gaze. Honor calls this “embodied AI”, meaning the assistant expresses itself through movement rather than only voice or text. The camera module can adjust its angle during video calls, which makes it feel a little more physically present.
According to Thomas Bai, AI product expert at Honor, the goal is to move beyond passive assistance. By combining sensing, movement and real-time processing, the device is designed to interact with its environment in a more continuous way. In practice, that could mean interpreting its surroundings and responding as situations change, such as when someone is moving through an unfamiliar space.
The Robot Phone has sparked curiosity, but there is still a lot we do not know. For one thing, it is still a prototype, with a release expected later this year. Early signs also suggest it may be expensive, partly because of rising memory chip costs. Some of its more playful features also feel uncertain. In demos, the phone can move along to music, but with only a handful of pre-set tracks, it is hard to tell whether that feature will be genuinely useful or remain more of a showcase moment.
Then there are the practical questions. A motorized camera system could make the phone heavier and more top-heavy, which may affect comfort during daily use. Running a motor alongside continuous AI tracking will also likely put pressure on battery life. These are not dealbreakers, but they are trade-offs that will matter outside of a demo.
Privacy is another concern that is hard to overlook. Some of the AI features rely on cloud processing, which means certain data is sent to external servers instead of being processed fully on the device. That is common in many AI systems today, but it feels more significant here because the phone is built to actively track movement and reposition its camera in real time. For some people, that level of autonomy may feel intrusive rather than helpful. It also raises bigger questions about what sensors are built into the device and how much data they collect during everyday use.
So, is the HONOR Robot Phone a real step forward, or just a clever idea packaged well?
The answer depends on who it is for.
For content creators, the appeal is obvious. Early indications suggest it could make video capture easier by reducing the need for extra gear. Honor’s collaboration with cinema camera company ARRI also suggests a serious push toward more cinematic smartphone footage.
For everyone else, the value is less clear. Outside of content creation, it is still hard to see how these features would translate into everyday use in a meaningful way.
For now, the Robot Phone sits somewhere between promise and experiment. Whether it turns into a genuinely useful new kind of smartphone or fades away as a novelty will only become clear once it moves beyond controlled demos and into real life.
Keep Reading
A closer look at how machine intelligence is helping doctors see cancer in an entirely new light.
Updated
January 8, 2026 6:33 PM

Serratia marcescens colonies on BTB agar medium. PHOTO: UNSPLASH
Artificial intelligence is beginning to change how scientists understand cancer at the cellular level. In a new collaboration, Bio-Techne Corporation, a global life sciences tools provider, and Nucleai, an AI company specializing in spatial biology for precision medicine, have unveiled data from the SECOMBIT clinical trial that could reshape how doctors predict cancer treatment outcomes. The results, presented at the Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting, highlight how AI-powered analysis of tumor environments can reveal which patients are more likely to benefit from specific therapies.
Led in collaboration with Professor Paolo Ascierto of the University of Napoli Federico II and Istituto Nazionale Tumori IRCCS Fondazione Pascale, the study explores how spatial biology — the science of mapping where and how cells interact within tissue — can uncover subtle immune behaviors linked to survival in melanoma patients.
Using Bio-Techne’s COMET platform and a 28-plex multiplex immunofluorescence panel, researchers analyzed 42 pre-treatment biopsies from patients with metastatic melanoma, an advanced stage of skin cancer. Nucleai’s multimodal AI platform integrated these imaging results with pathology and clinical data to trace patterns of immune cell interactions inside tumors.
The findings revealed that therapy sequencing significantly influences immune activity and patient outcomes. Patients who received targeted therapy followed by immunotherapy showed stronger immune activation, marked by higher levels of PD-L1+ CD8 T-cells and ICOS+ CD4 T-cells. Those who began with immunotherapy benefited most when PD-1+ CD8 T-cells engaged closely with PD-L1+ CD4 T-cells along the tumor’s invasive edge. Meanwhile, in patients alternating between targeted and immune treatments, beneficial antigen-presenting cell (APC) and T-cell interactions appeared near tumor margins, whereas macrophage activity in the outer tumor environment pointed to poorer prognosis.
“This study exemplifies how our innovative spatial imaging and analysis workflow can be applied broadly to clinical research to ultimately transform clinical decision-making in immuno-oncology”, said Matt McManus, President of the Diagnostics and Spatial Biology Segment at Bio-Techne.
The collaboration between the two companies underscores how AI and high-plex imaging together can help decode complex biological systems. As Avi Veidman, CEO of Nucleai, explained, “Our multimodal spatial operating system enables integration of high-plex imaging, data and clinical information to identify predictive biomarkers in clinical settings. This collaboration shows how precision medicine products can become more accurate, explainable and differentiated when powered by high-plex spatial proteomics – not limited by low-plex or H&E data alone”.
Dr. Ascierto described the SECOMBIT trial as “a milestone in demonstrating the possible predictive power of spatial biomarkers in patients enrolled in a clinical study”.
The study’s broader message is clear: understanding where immune cells are and how they interact inside a tumor could become just as important as knowing what they are. As AI continues to map these microscopic landscapes, oncology may move closer to genuinely personalized treatment — one patient, and one immune network, at a time.